In 45 control rats and 47 nephrectomized, DOCA-implanted, hypertensive rats (hypertensive phase), blood pressure, weight gain, development of pathologic-anatomical histological changes as well as changes in the myocardial enzyme pattern were studied over 24 weeks and after absorption of the DOCA tablet the return of the animals to normal conditions (follow-up phase) for another 14 weeks. During the hypertensive phase, blood pressure rose to 233 mm Hg on the average within 10 weeks and remained constant up to the 22nd week. In the follow-up phase, it dropped sharply, at first, and then slowly returned to normal. Weight gain was the same in DOCA and control rats. Relative weights of heart, kidneys and liver were elevated in the hypertensive phase but fell again in the follow-up phase. The pathologic-histological changes formed in the hypertensive phase, such as myocardial hypertrophy, glomerular hyalinization, tubular dilation and perivascular fibrosis, were remitted in part. Unchanged, however, the enhanced heart score persisted evidencing a proliferative vasoconstriction. Except for a pronounced, reversible increase in MAO activity, the cardial enzyme pattern remained unchanged during the experiment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hypertensive phase
16
blood pressure
12
follow-up phase
12
control rats
8
phase blood
8
weight gain
8
enzyme pattern
8
phase
7
hypertensive
5
[the course
4

Similar Publications

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting.

Alzheimers Dement (Amst)

January 2025

Neurochemistry Laboratory Department of Laboratory Medicine Amsterdam UMC Amsterdam The Netherlands.

Introduction: Blood-based glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and phosphorylated tau (pTau) have shown promising prognostic potential in Alzheimer's disease (AD), but their applicability in clinical settings where comorbidities are prevalent remains uncertain.

Methods: Simoa assays quantified GFAP, NfL, and pTau181 in retrospectively retrieved prediagnostic serum samples from 102 AD patients and 21 non-AD controls.

Results: Higher serum GFAP levels predicted earlier clinical presentation and faster subsequent Mini-Mental State Examination decline in AD patients.

View Article and Find Full Text PDF

Long-Term Stabilized and Highly Soluble Bezafibrate-Gliclazide Co-Amorphous Binary System.

AAPS PharmSciTech

January 2025

School of Engineering and Sciences, Tecnologico de Monterrey, Campus Monterrey, Ave. Eugenio Garza Sada 2501 Sur, C.P. 64849, Monterrey, N.L., Mexico.

Metabolic syndrome (MS) has a high prevalence, with an estimated one-quarter of the world population affected by this pathological condition. Among the diseases of this syndrome are dysregulation of lipids, hypertension, and insulin resistance. Unfortunately, available drugs in the market used for treating MS, as almost 75% of all drugs, are highly insoluble, presenting a significant demand for strategies to increase their solubility.

View Article and Find Full Text PDF

Primary aldosteronism (PA) is a common, potentially reversible, cause of hypertension. Distinguishing unilateral from bilateral PA is critical when deciding who should be offered surgery (unilateral adrenalectomy). Recent studies have shown that PET/CT with [C]metomidate can accurately identify unilateral PA, with localization of the causative aldosterone-producing adenoma (APA).

View Article and Find Full Text PDF

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.

Eur Respir J

January 2025

Université Paris-Saclay, INSERM Unité Mixte de Recherche en Santé 999 (HPPIT), Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre (Assistance Publique-Hôpitaux de Paris), Le Kremlin-Bicêtre, France.

Introduction: Pulmonary arterial hypertension (PAH) is a progressive disease associated with significant morbidity and mortality. Sotatercept is a first-in-class activin signalling inhibitor that acts to restore the balance between the growth-promoting and growth-inhibiting signalling pathways.

Methods: This post-hoc, exploratory, pooled analysis combines data from the double-blind placebo periods of the phase 2 PULSAR (NCT03496207) and phase 3 STELLAR (NCT04576988) studies.

View Article and Find Full Text PDF

Post-acid modification-enhanced gelation of casein-tamarind seed polysaccharide-based medium internal phase emulsion and its application in 3D printing.

Int J Biol Macromol

January 2025

National Engineering Research Center of Seafood, Collaborative Innovation Center of Provincial and Ministerial Co-construction for Seafood Deep Processing, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, PR China. Electronic address:

Printable protein-based medium internal phase emulsions (MIPEs) with low oil fraction have the advantages of reducing the incidence of obesity, coronary heart disease and hypertension. However, the development of printable protein-based MIPEs is still a considerable challenge because reducing oil content will cause phase separation and increase the fluidity of emulsion. In this study, we successfully prepared printable MIPEs (φ = 40 %) inks by co-stabilizing with casein and tamarind seed polysaccharide (TSP) and using post-acid modification technology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!